Table 3 Respondents who agreed or strongly agreed with organisations accessing and using their genomic data and being able to re-identify individuals from their stored data.

From: Secondary use of genomic data: patients’ decisions at point of testing and perspectives to inform international data sharing

Type of Organisation

Agree with access and use of genomic data

Agree with ability to re-identify

Members of the Alliance#

868/908 (96%)

695/899 (77%)

Researchers at Australian not-for-profit organisations

699/899 (78%)

379/895 (42%)

Researchers at not-for-profit organisations abroad

537/892 (60%)

269/895 (30%)

Researchers at pharmaceutical companies

484/894 (54%)

248/893 (30%)

Government

375/888 (42%)

238/881 (27%)

Researchers in other industries

315/887 (36%)

177/893 (20%)

  1. #researchers at organisations that are members of the Melbourne Genomics or Australian Genomic Health Alliances.